Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF

Standard treatments for nonsmall cell lung cancer (NSCLC), such as surgery, chemotherapy, and radiotherapy, often lead to disappointing results. Unfortunately, also the various immunotherapeutic approaches so far tested have not produced satisfactory results to be widely applied in the clinical prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Corti, Angelo, Giovannini, Monica, Belli, Carmen, Villa, Eugenio
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896845/
https://www.ncbi.nlm.nih.gov/pubmed/20613952
http://dx.doi.org/10.1155/2010/732680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896845/
https://www.ncbi.nlm.nih.gov/pubmed/20613952
http://dx.doi.org/10.1155/2010/732680

Ejemplares similares